These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

231 related items for PubMed ID: 19016696

  • 1. Activation of the mammalian target of rapamycin signalling pathway in epidermal tumours and its correlation with cyclin-dependent kinase 2.
    Chen SJ, Nakahara T, Takahara M, Kido M, Dugu L, Uchi H, Takeuchi S, Tu YT, Moroi Y, Furue M.
    Br J Dermatol; 2009 Feb; 160(2):442-5. PubMed ID: 19016696
    [Abstract] [Full Text] [Related]

  • 2. Immunohistochemical analysis of the mammalian target of rapamycin signalling pathway in extramammary Paget's disease.
    Chen S, Nakahara T, Uchi H, Takeuchi S, Takahara M, Kido M, Dugu L, Tu Y, Moroi Y, Furue M.
    Br J Dermatol; 2009 Aug; 161(2):357-63. PubMed ID: 19438435
    [Abstract] [Full Text] [Related]

  • 3. Cyclin A and beta-catenin expression in actinic keratosis, Bowen's disease and invasive squamous cell carcinoma of the skin.
    Brasanac D, Boricic I, Todorovic V, Tomanovic N, Radojevic S.
    Br J Dermatol; 2005 Dec; 153(6):1166-75. PubMed ID: 16307653
    [Abstract] [Full Text] [Related]

  • 4. Mammalian target of rapamycin, a molecular target in squamous cell carcinomas of the head and neck.
    Amornphimoltham P, Patel V, Sodhi A, Nikitakis NG, Sauk JJ, Sausville EA, Molinolo AA, Gutkind JS.
    Cancer Res; 2005 Nov 01; 65(21):9953-61. PubMed ID: 16267020
    [Abstract] [Full Text] [Related]

  • 5. Phosphorylated 4E binding protein 1: a hallmark of cell signaling that correlates with survival in ovarian cancer.
    Castellvi J, Garcia A, Rojo F, Ruiz-Marcellan C, Gil A, Baselga J, Ramon y Cajal S.
    Cancer; 2006 Oct 15; 107(8):1801-11. PubMed ID: 16983702
    [Abstract] [Full Text] [Related]

  • 6. Paradigm of kinase-driven pathway downstream of epidermal growth factor receptor/Akt in human lung carcinomas.
    Dobashi Y, Suzuki S, Kimura M, Matsubara H, Tsubochi H, Imoto I, Ooi A.
    Hum Pathol; 2011 Feb 15; 42(2):214-26. PubMed ID: 21040950
    [Abstract] [Full Text] [Related]

  • 7. The Akt/mammalian target of rapamycin signal transduction pathway is activated in high-risk myelodysplastic syndromes and influences cell survival and proliferation.
    Follo MY, Mongiorgi S, Bosi C, Cappellini A, Finelli C, Chiarini F, Papa V, Libra M, Martinelli G, Cocco L, Martelli AM.
    Cancer Res; 2007 May 01; 67(9):4287-94. PubMed ID: 17483341
    [Abstract] [Full Text] [Related]

  • 8. Differential expression of ezrin in epithelial skin tumors: cytoplasmic ezrin immunoreactivity in squamous cell carcinoma.
    Park HR, Min SK, Min K, Jun SY, Seo J, Kim KH, Choi J.
    Int J Dermatol; 2010 Jan 01; 49(1):48-52. PubMed ID: 20465611
    [Abstract] [Full Text] [Related]

  • 9. Critical and diverse involvement of Akt/mammalian target of rapamycin signaling in human lung carcinomas.
    Dobashi Y, Suzuki S, Matsubara H, Kimura M, Endo S, Ooi A.
    Cancer; 2009 Jan 01; 115(1):107-18. PubMed ID: 19090006
    [Abstract] [Full Text] [Related]

  • 10. Activation of fibroblast growth factor receptor 3 and oncogene-induced senescence in skin tumours.
    Hida Y, Kubo Y, Arase S.
    Br J Dermatol; 2009 Jun 01; 160(6):1258-63. PubMed ID: 19298285
    [Abstract] [Full Text] [Related]

  • 11. Morphoproteomic and molecular concomitants of an overexpressed and activated mTOR pathway in renal cell carcinomas.
    Lin F, Zhang PL, Yang XJ, Prichard JW, Lun M, Brown RE.
    Ann Clin Lab Sci; 2006 Jun 01; 36(3):283-93. PubMed ID: 16951269
    [Abstract] [Full Text] [Related]

  • 12. Stromal CD10 expression, as well as increased dermal macrophages and decreased Langerhans cells, are associated with malignant transformation of keratinocytes.
    Takahara M, Chen S, Kido M, Takeuchi S, Uchi H, Tu Y, Moroi Y, Furue M.
    J Cutan Pathol; 2009 Jun 01; 36(6):668-74. PubMed ID: 19515046
    [Abstract] [Full Text] [Related]

  • 13. AKT activation in human glioblastomas enhances proliferation via TSC2 and S6 kinase signaling.
    Riemenschneider MJ, Betensky RA, Pasedag SM, Louis DN.
    Cancer Res; 2006 Jun 01; 66(11):5618-23. PubMed ID: 16740698
    [Abstract] [Full Text] [Related]

  • 14. IGF-1-stimulated protein synthesis in oligodendrocyte progenitors requires PI3K/mTOR/Akt and MEK/ERK pathways.
    Bibollet-Bahena O, Almazan G.
    J Neurochem; 2009 Jun 01; 109(5):1440-51. PubMed ID: 19453943
    [Abstract] [Full Text] [Related]

  • 15. Octreotide and the mTOR inhibitor RAD001 (everolimus) block proliferation and interact with the Akt-mTOR-p70S6K pathway in a neuro-endocrine tumour cell Line.
    Grozinsky-Glasberg S, Franchi G, Teng M, Leontiou CA, Ribeiro de Oliveira A, Dalino P, Salahuddin N, Korbonits M, Grossman AB.
    Neuroendocrinology; 2008 Jun 01; 87(3):168-81. PubMed ID: 18025810
    [Abstract] [Full Text] [Related]

  • 16. Immunohistochemical comparison of beta-catenin expression by human normal epidermis and epidermal tumors.
    Fukumaru K, Yoshii N, Kanzaki T, Kanekura T.
    J Dermatol; 2007 Nov 01; 34(11):746-53. PubMed ID: 17973813
    [Abstract] [Full Text] [Related]

  • 17. Morphoproteomic and pharmacoproteomic rationale for mTOR effectors as therapeutic targets in head and neck squamous cell carcinoma.
    Brown RE, Zhang PL, Lun M, Zhu S, Pellitteri PK, Riefkohl W, Law A, Wood GC, Kennedy TL.
    Ann Clin Lab Sci; 2006 Nov 01; 36(3):273-82. PubMed ID: 16951268
    [Abstract] [Full Text] [Related]

  • 18. Antagonism of the mammalian target of rapamycin selectively mediates metabolic effects of epidermal growth factor receptor inhibition and protects human malignant glioma cells from hypoxia-induced cell death.
    Ronellenfitsch MW, Brucker DP, Burger MC, Wolking S, Tritschler F, Rieger J, Wick W, Weller M, Steinbach JP.
    Brain; 2009 Jun 01; 132(Pt 6):1509-22. PubMed ID: 19416948
    [Abstract] [Full Text] [Related]

  • 19. Insulin and IGF-1 enhance the expression of the neuronal monocarboxylate transporter MCT2 by translational activation via stimulation of the phosphoinositide 3-kinase-Akt-mammalian target of rapamycin pathway.
    Chenal J, Pierre K, Pellerin L.
    Eur J Neurosci; 2008 Jan 01; 27(1):53-65. PubMed ID: 18093179
    [Abstract] [Full Text] [Related]

  • 20. Statin-dependent suppression of the Akt/mammalian target of rapamycin signaling cascade and programmed cell death 4 up-regulation in renal cell carcinoma.
    Woodard J, Sassano A, Hay N, Platanias LC.
    Clin Cancer Res; 2008 Jul 15; 14(14):4640-9. PubMed ID: 18628479
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.